ClearPoint Neuro, Inc. (CLPT) financial statements and ratios from SEC XBRL: revenue $36.97M (TTM), net margin -69.1%, revenue growth 17.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $36.97M |
| Net Margin | -69.1% |
| Revenue Growth (YoY) | 17.8% |
| EPS Growth (YoY) | 28.6% |
| FCF Growth (YoY) | 165.0% |
| Price / Book | 43.00 |
| Price / Sales | 10.53 |
| FCF Yield | -7.1% |
| Altman Z-Score | 0.98 (distress) |
| Sector P/E (Healthcare) | 21.6 |
CLPT overview · CLPT earnings · CLPT KPIs · CLPT investor relations · CLPT ownership · CLPT peers · CLPT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.